Derms and Conditions
Hear from leading dermatologists and experts as they discuss the hottest topics in dermatology. Tune in for clinical practice tips and treatment pearls you can implement quickly and efficiently into your busy practices.
Episodes
The Business of Dermatology
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Cory Rubin, MD, for a candid look at the business of dermatology. Drawing on his experience building an independent practice, Dr Rubin discusses what it takes to move from clinician to practice owner, from the freedom to pursue new opportunities to the responsibility of leading a team, managing finances, and making deci
Dermatomyositis in 2026: Are You Missing Anything Important in Real-World Practice?
In this episode, host James Q. Del Rosso, DO, welcomes dermatologist and rheumatologist Joseph Merola, MD, to discuss the diagnosis and management of dermatomyositis (DM). From subtle cutaneous clues and systemic involvement to malignancy risk, myositis-specific antibodies, and an expanding treatment pipeline, Dr Merola highlights what dermatologists should recognize when DM enters the differentia
Sunscreens 2026: The Evolution of Expanded Photoprotection and A New Filter
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Darrell Rigel, MD, MS, for a discussion of photoprotection, sunscreen regulation, and how dermatologists can help patients make informed choices about sun protection.
Dr Rigel begins by examining why melanoma prevention requires attention to both primary and secondary prevention. While reducing UV exposure and usi
Spilling the Tea: Important Observations to Help Clinicians
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, delivers a solo “Spilling the Tea” segment exploring clinical observations that may warrant a closer look. He examines dermatomyositis findings that can mimic more common conditions, nuances in prescribing language, the importance of a thorough hidradenitis suppurativa (HS) examination, and an unexpected case of rhabdomyoly
Preventing Permanent Hair Loss: Early Diagnosis and Treatment of Scarring Alopecia
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Andrea Murina, MD, to discuss the early recognition and management of scarring alopecias. Their conversation explores why these conditions can be missed in their earliest stages, the clinical clues that help distinguish scarring from nonscarring alopecias, and approaches to diagnosis and treatment aimed at preventi
A Call to Action: Making Practice Guidelines More Helpful to Patient Care
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Joshua Burshtein, MD, chief dermatology resident at the University of Illinois Chicago, to discuss their recent Journal of Clinical and Aesthetic Dermatology publication, Topical Prescription Therapy for Psoriasis: An Expert Position Paper on Limitations of Published Guidelines and Treatment Selectio
Translating Cytokine Soup to Clinical Practice: Untangling the Confusion
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Jason Hawkes, MD, MS, for a special Tea with Dr. D edition exploring the immunology that underpins inflammatory skin disease and how a deeper understanding of cytokine biology can inform clinical decision-making.
The discussion begins by challenging the common tendency to classify diseases according to a
Anti-IL-23 Biologic Therapy: Expanding our Knowledge and Access for Patients with Psoriasis
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes E. James Song, MD, for a discussion of the IL-23 pathway and its enduring role in psoriasis management. Although therapeutic options continue to expand, IL-23 remains a central target because of its key role in the IL-23/Th17 axis, one of the primary drivers of psoriatic disease.
Dr Song reviews the current IL-23
Topical Therapy for AD: How Can an AhR Agonist Make a Difference?
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Alexandra Golant, MD, for a discussion on the evolving role of topical therapies in atopic dermatitis (AD). While systemic therapies have transformed care for patients with moderate to severe disease, this discussion explores how topical treatments remain essential, not only for managing flares but also for maintai
How Contactants Can Influence the Clinical Picture of AD
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Walter Liszewski, MD, for a discussion on the role of patch testing in patients with atopic dermatitis (AD), from the fundamentals of testing and interpretation to its application in patients with persistent or incomplete responses to therapy.
Dr Liszewski explains why allergic contact dermatitis is frequently ove
Unpacking My Dermatology Past: Sharing What I've Learned Along the Way to Improve Patient Care
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, sits down with Melinda Gooderham, MD, for a wide-ranging conversation about the evolution of dermatology, clinical research, and the therapeutic advances that have transformed patient care over the course of her career.
Dr Gooderham reflects on how an early frustration with patient access to emerging biologic therapies led her
Managing HS: What A Difference A Year Makes!
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes back Michael Payette, MD, a dermatologist in private practice in Connecticut, for a wide-ranging discussion on the realities of managing hidradenitis suppurativa (HS) in clinical practice.
Drawing from his experience running a dedicated HS clinic, Dr Payette reflects on what surprised him most after launching the pract
Oral Isotretinoin: Where Are We After 44 Years?
In this episode of Tea with Dr. D, host James Q. Del Rosso delivers a solo “Spilling the Tea” segment that revisits oral isotretinoin through a longitudinal lens, connecting its early clinical foundations to present-day practice.
Framing isotretinoin as a “winding road,” Dr Del Rosso reflects on its 1982 approval, early safety observations, and the evolution of risk management strategies, includi
The Life of Leon: How He Succeeds and He Makes It Look Easy
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Leon Kircik, MD, for a wide-ranging conversation that traces Dr Kircik’s journey from his upbringing in Turkey to building a thriving dermatology practice and research center in Louisville, Kentucky, and ultimately becoming one of the leading educators in the field.
Dr Kircik reflects on the early influence of his fat
How Does Modern-Day Compounding Create Uncertainty, Inconsistency & Risk to Patients?
In this episode of Derms and Conditions, host James Q. Del Rosso, DO is joined by Stefan Weiss, MD for a focused discussion on compounding in dermatology, an area that often operates with less visibility but carries important clinical implications.
The conversation centers on the regulatory and practical differences between 503A and 503B compounding pharmacies, with particular attention to 503A f
Changing Conversations in Acne Management
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, is joined by Heather Woolery-Lloyd, MD, for a treatment-focused discussion on acne management in an era where patient expectations, product awareness, and regimen complexity continue to rise.
The conversation opens with a shift many dermatologists are seeing in practice: patients arriving more informed and more influenced by
Acne Therapy: It’s Not Just the Tools You Have—It’s How You Use Them!
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, is joined by Hilary Baldwin, MD, for a treatment-focused discussion on acne management, with particular attention to how newer topical therapies are reshaping treatment approaches.
They begin by reflecting on how patient expectations and therapeutic options have shifted over the past decade. Dr Baldwin highlights improvements i
Attention to Lupus is Long Overdue! Better Understanding of Disease Leads to Better Therapies
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Joseph Merola, MD, for a clinically focused discussion on updates in cutaneous lupus erythematosus (CLE). Long considered an area with limited therapeutic progress, CLE is gaining renewed attention as advances in disease biology and immunopathogenesis begin to inform new therapeutic approaches.
They begin by discu
Modern Training Of Future Dermatologists: Maintaining Core Fundamentals In A Rapidly Changing Educational Landscape
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Michelle Tarbox, MD, for a candid discussion about the realities of leading a dermatology department and training the next generation of dermatologists.
Dr Tarbox reflects on the vision she brought to her role as department chair and the principles that guide her approach to residency education. Central to that philoso
Challenging Recycled Dogma: Fine-Tuning Accuracy to Improve Patient Care
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes David Seiter, FNP-C, for a wide-ranging discussion on challenging dermatologic dogma and integrating emerging evidence into clinical decision-making.
They begin with Seiter sharing his approach to reviewing new literature, encouraging clinicians to look beyond mainstream dermatology journals to cross-disciplinary publi
How to Manage Acne From the Start: Practical Tips on Integrating Newer Topical Approaches
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Lisa Swanson, MD, to explore how acne management continues to evolve and how newer topical therapies can be integrated thoughtfully from the outset.
They begin with Dr Swanson highlighting an important clinical reality: acne is presenting at increasingly younger ages, prompting earlier conversations about skin care rou
Walking Through a Work Week With Dr Daveluy: Lessons Learned
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, is joined by Steven Daveluy, MD, for a wide-ranging conversation that connects oncodermatology, teledermatology, and integrative approaches to patient care.
The discussion opens with Dr Daveluy’s work in an oncodermatology clinic and the critical role dermatologists play in managing cutaneous side effects from cancer therapies.
Navigating the Twists and Turns: From Residency Training to Department Chair with Several Stops In Between
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, sits down with Laura Ferris, MD, to explore the path to, and realities of, serving as a department chair in academic dermatology.
They begin with Dr Ferris describing the motivations that led her to consider a leadership role, sharing the self-reflective questions that guided her thinking, including how to continue growing prof
Mast Cell Disease: The Elusive Instigator You’re Likely to See but Not Recognize
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Lauren Madigan, MD, associate professor of dermatology at the University of Utah, for a focused exploration of mast cell disease, an often underrecognized but clinically significant group of disorders that dermatologists may encounter on the front lines.
The conversation begins with mast cell biology, including their o
From the Benchtop to the Treatment Room: Important Questions Answered About Topical Clascoterone
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, is joined by Zoe Draelos, MD, for an in-depth discussion of 3 practical questions surrounding topical clascoterone, informed by studies Dr Draelos helped conduct. Together, they translate study findings into real-world considerations for using clascoterone as part of combination acne regimens.
The conversation begins with the r
Young Guns in Dermatology 2: Being a Dermatology Detective
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, is joined by Nicholas Brownstone, MD, practicing dermatologist and host of the Cutaneous Miscellaneous podcast, for a case-based discussion on how dermatologists think through challenging presentations and refine their diagnostic approach. Together, they offer takeaways that residents, early-career dermatologists, and experience
Greatest Hits of Derms and Conditions 2025
In this 2025 Year in Review solo episode of Derms and Conditions, host James Q. Del Rosso, DO, reflects on the standout conversations, clinical insights, and new formats that shaped the series over the past year.
Dr Del Rosso opens by highlighting the launch of Tea with Dr. D, a sister vodcast that brings expert discussions to video, incorporating slides and procedural footage. He spotlights an e
Watch and Listen: How You Can Integrate Regenerative Procedures to Treat Alopecia
In this episode of Tea with Dr. D, host James Q. Del Rosso, DO, is joined by Gary Goldenberg, MD, for an in-depth discussion on integrating procedural dermatology, particularly regenerative treatments for hair loss, into a busy private practice. Together, they explore considerations for patient selection and the clinical value these procedures bring to aesthetic and medical dermatology settings.
Pearls from “The Pearl”: A Time Capsule of Knowledge & Experience with Vitiligo
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, sits down with Pearl Grimes, MD, to discuss the latest understanding and management of vitiligo, a field experiencing significant scientific and therapeutic momentum. With the approval of topical ruxolitinib and multiple oral JAK inhibitors on the horizon, these developments are enabling clinicians to better tailor therapy to th
Spilling the Tea with Dr D: Your Dermatology Questions Answered
In this episode of Tea with Dr. D, host James Q. Del Rosso, DO, tackles questions submitted by dermatology clinicians across the country, offering evidence-based insights across several challenging clinical topics.
Dr Del Rosso begins with hidradenitis suppurativa (HS), highlighting the importance of recognizing comorbidities and lifestyle factors that contribute to disease onset and progression,
Two Valuable Perspectives from Two Brilliant Dermatologists: Expanding the Value of Topical PDE4 Inhibition
In this episode of Tea with Dr D, host James Q. Del Rosso, DO, is joined by Christopher Bunick, MD, PhD, and later Lisa Swanson, MD, for a deep look at phosphodiesterase-4 (PDE4) inhibition in dermatology, with a special focus on topical roflumilast.
Dr Bunick opens with a primer on the science of PDE4, an enzyme that degrades cyclic AMP (cAMP), an intracellular messenger that regulates anti-inf
Greatest Hits: Live from Fall Clinical Dermatology 2025
In this special Derms and Conditions episode recorded live at Fall Clinical 2025, host James Q. Del Rosso, DO, is joined by April Armstrong, MD, MPH, and David Cohen, MD, to share highlights and clinical takeaways from this year’s meeting.
Dr Armstrong kicks off with updates in hidradenitis suppurativa (HS), noting the field’s rapid progress with 3 FDA-approved therapies (adalimumab, secukinumab,
A Topical Marriage Made in Heaven: The Right Active Ingredient Meets the Right Formulator
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes David Osborne, PhD, a formulation expert behind several dermatologic topicals, to explore what drives topical performance, using dapsone and roflumilast as case studies.
They begin by challenging long-held vehicle dogma rooted in mid-20th-century corticosteroid training: the idea that ointments always outperform creams
Shedding New Light on Phototherapy: Now in the Comfort of Your Own Home
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, sits down with E. James Song, MD, for a discussion on phototherapy and its place in modern dermatology. While phototherapy has long been a safe and effective treatment for various skin disorders, its use has declined due to limited access, inconsistent residency training, and clinician concerns about dosing. They review why thes
Alopecia Areata Update: There's A New Kid in Town
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, is joined by Natasha Mesinkovska, MD, associate professor of Dermatology at UC Irvine, to discuss the multifaceted challenges of alopecia areata (AA), an autoimmune condition with complex comorbidities and broad psychosocial implications.
The conversation begins with the stigma of hair loss and the importance of addressing the
Here Comes the Sun: Little Darlin', Use Your Sunscreen!
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Patti Farris, MD, associate clinical professor of dermatology at Tulane University, for a timely conversation on photoprotection and sunscreen. As new concerns surface among patients, they provide an up-to-date perspective on UV exposure, formulation science, and patient counseling.
Dr Farris explains the critical role
Tea with Dr. D is Back Again! How Would You Have Handled These Cases?
In this new installment of Tea with Dr D, host James Q. Del Rosso, DO, is joined by Karan Lal, DO, to examine 3 complex cases where clinical reasoning required moving beyond conventional pathways. This episode features visually impactful case images that bring the discussion to life.
The first case centers on an elderly patient on PD-L1 immunotherapy who developed erosive plaques on the head and
Oral Tetracyclines for Rosacea: Previous and Newer Therapies
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Dallas/Fort Worth–based dermatologist Todd Plott, MD, for an in-depth discussion on the first extended-release formulation of minocycline approved for rosacea.
The conversation begins with a historical look at tetracyclines, tracing back to tetracycline in 1953, doxycycline in 1968, and minocycline in 1971. While tradi
Index of Suspicion is the Friend of the Clinician: Great Cases from the Northeast
Index of Suspicion is the Friend of the Clinician: Great Cases from the Northeast
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Erik Domingues, MD, a dermatologist in Fall River, MA, to review 3 cases where cutaneous presentations led to unexpected findings or required creative treatment approaches.
The first case involves a 74-year-old man with diffuse gra
Getting the Upper Hand on CHE! Observations from a Principal Investigator
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes April Armstrong, MD, MPH, Professor and Chief of Dermatology at UCLA, to discuss chronic hand eczema (CHE) and the introduction of the first FDA-approved treatment developed specifically for this condition.
The conversation begins with a review of CHE as a distinct clinical entity, highlighting its subtypes: irritant c
The Data Speaks for Itself: TYK2 Take 2 with Dr Andy Blauvelt
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, is joined by Andy Blauvelt, MD, to explore the mechanism, efficacy, and safety of deucravacitinib, the first FDA-approved tyrosine kinase 2 (TYK2) inhibitor for psoriasis.
Dr Blauvelt begins by explaining how TYK2 inhibition differs from traditional JAK inhibition by targeting a more selective signaling pathway downstream of cy
Detroit Has Motown, Motor Vehicles, and Some Challenging Dermatology Cases!
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes David Altman, MD, dermatologist at Midwest Center of Dermatology in Warren, MI, to review recent case studies that highlight unexpected presentations, treatment responses, and immune system interplay in dermatology.
The first case focuses on a 34-year-old patient with severe, recalcitrant Hailey-Hailey disease. After m
A Youthful Approach to Maintaining Youthful & Healthy Skin: Here is How!
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, speaks with Heather Woolery-Lloyd, MD, dermatologist and director of the Skin of Color division at the University of Miami, about the shifting dynamics of skin care among younger generations and how dermatologists can meet this growing demand for evidence-based “prejuvenation” strategies.
The discussion begins with reflections
Chronic Hives Are Back! New Perspectives on Evaluation and Management
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, sits down with Jason Hawkes, MD, Chief Scientific Officer at Oregon Medical Research Center, to explore the role of dupilumab in chronic spontaneous urticaria (CSU), a condition historically managed outside dermatology.
They begin with the immunologic underpinnings of CSU, explaining the role of IL-4 and IL-13 in driving mast c
Young Guns in Dermatology 1: Conquer Challenges with Collaboration
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, is joined by Diego Ruiz DaSilva, MD, dermatologist at Forefront Dermatology and assistant professor at Eastern Virginia Medical School. Together, they discuss Dr DaSilva’s recent publications and his journey in building a collaborative research career focused on real-world clinical insights.
To begin, Dr DaSilva shares the ins
Improving Treatment of Facial Hyperpigmentation: What You Need To Know
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, sits down with Cheri Frey, MD, residency program director and director of cosmetic dermatology at Howard University, to discuss the clinical nuances of facial hyperpigmentation, with a special focus on melasma and the emerging role of Thiamidol.
Dr Frey begins by breaking down how she categorizes facial hyperpigmentation that
Patience, Persistence, and Positivity: A New Era in Vitiligo Treatment
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, is joined by a world expert in pigmentation, Seemal R. Desai, MD, founder of Innovative Dermatology in Dallas, Texas, for a timely, clinically focused discussion on vitiligo.
Dr Desai begins by outlining how to identify unstable vitiligo at the first visit, a crucial step that guides treatment decisions. He describes hallmark f
Mailbag 2: Your Questions Answered
In this special mailbag episode of Derms and Conditions, James Q. Del Rosso, DO, takes on your questions from the field, offering expert guidance and real-world tips on some of the most common challenges in dermatology today.
Dr Del Rosso begins by tackling common challenges with oral apremilast for psoriasis, sharing strategies to manage gastrointestinal side effects and improve patient adheren
Nonsteroidal Topical Rx for AD: From Study Room to Clinic Room
In this episode of Derms and Conditions, Dr James Q. Del Rosso is joined by Dr Adelaide Hebert, Chief of Pediatric Dermatology at McGovern School of Medicine and Children’s Memorial Hermann Hospital in Houston, Texas. Back by popular demand, Dr Hebert shares her clinical experience managing pediatric atopic dermatitis—particularly in patients who are treatment resistant, injection-averse, or fearf
Optimized Photoprotection in 2025: Combining Protection & Correction for Photodamage
In this episode of Derms and Conditions, Dr James Q. Del Rosso welcomes esteemed dermatologist Dr Henry Lim from Michigan. Together, they explore the evolving science behind photoprotection, the importance of advances in sunscreen formulations and ingredients, and the clinical relevance of sunscreen formulations that both protect against and repair photodamage.
Dr Lim provides an update on compr
Another Cup of Tea with Dr D! Part 2: Closing the Loop on Managing HS
In Part Two of the Tea with Dr. D premiere, James Q. Del Rosso, DO, returns with Lauren Lam, MD, a Canadian dermatologist with a keen interest and extensive experience in managing hidradenitis suppurativa (HS). After covering overall considerations and the medical side of HS management in Part One, they shift gears to focus on important physical approaches, including one of the most effective—and
Tea with Dr D: Solving The Puzzle of Hidradenitis Suppurativa: Pulling All the Pieces Together for Each Patient
In this premiere episode of Tea with Dr D, Dr James Q Del Rosso welcomes Dr Lauren Lam, a Canadian dermatologist with special interest and strong experience in managing patients affected by hidradenitis suppurativa (HS). They engage in a thoughtful and comprehensive conversation about diagnosing and treating this common yet often elusive skin condition—especially in its early stages—which has been
Mailbag 1: Your Questions Answered
In this first mailbag edition of Derms and Conditions, Dr James Q. Del Rosso flies solo to answer your questions—submitted by clinicians across the country. From potassium monitoring to topical field therapy, it’s a rapid-fire round of guidance grounded in the latest literature, clinical experience, and practical wisdom.
Dr Del Rosso kicks things off with the ever-popular question: Do I really ne
Wrapping Our HANDS Around Managing Chronic Hand Eczema
In this episode of Derms and Conditions, host Dr James Del Rosso speaks with Dr Linda Stein Gold, Director of Dermatology at Henry Ford Health, to unpack one of dermatology’s most frustrating and multifactorial conditions: chronic hand eczema.
They explore why chronic hand eczema isn’t a single disease but a spectrum of overlapping etiologies—ranging from atopic dermatitis and irritant or allergi
Oral Therapy for Psoriasis: Valuable Insights from April in April!
In this episode of Derms and Conditions, Dr James Q Del Rosso is joined by Dr April Armstrong, Chair of Dermatology at UCLA, for a thorough discussion of oral therapies for plaque psoriasis—what’s new, what still works, and how to choose the right treatment for the right patient.
They kick off with a practical discussion on older systemic options like methotrexate and
cyclosporine, including when
Whom Do You Trust? Learn More About Trusts & Wills
In this episode of Derms and Conditions, Dr James Q. Del Rosso shifts gears from clinical
dermatology to something equally important but rarely discussed—legal and financial planning.
He’s joined by his longtime friend and dermatopathologist, Dr Clay Cockerell, who also happens
to be a licensed attorney with a passion for educating physicians about estate planning.
Dr Cockerell breaks down the fu
Atopic Dermatitis in Kids: Non-Steroidal Advances with Dr Lisa Swanson Episode Summary
In this episode of Derms and Conditions, Dr James Q. Del Rosso welcomes back his
longtime friend and pediatric dermatology expert, Dr Lisa Swanson. Together, they
explore the rapidly evolving treatment landscape for pediatric atopic dermatitis, with a
focus on newly approved non-steroidal topical therapies.
Dr Swanson shares her insights on tapinarof 1% cream, now FDA-approved for patients
as you
Poster Power: A Review of Selected Highlights from WCM25
In this episode of Derms and Conditions, host Dr James Q. Del Rosso returns from the 2025
Winter Clinical Dermatology Conference – Miami® with a deep dive into some of the standout
posters presented at the meeting.
Dr Del Rosso begins the review with new insights on topical clascoterone 1% cream and its
impact on the skin barrier, tolerability, and sebum reduction. He explores recent studies
show
Highlights from Winter Clinical Hawaii 2025: Recorded Live on The Big Island
In this special live episode of Derms and Conditions, recorded at the 2025 Winter Clinical Dermatology Conference - Hawaii®, host Dr James Q. Del Rosso welcomes Dr April Armstrong, chief of dermatology at UCLA, and Dr David Cohen, dermatologist at NYU Langone, to break down the key takeaways from this year’s meeting.
The discussion kicks off with chronic hand eczema, a condition that can be diff
"Don't Sweat It" You Say? With Once A Day, There Is A Way!
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Lawrence Green, MD, clinical professor at George Washington University and practicing dermatologist, to discuss the evolving landscape of hyperhidrosis and the latest FDA-approved therapy, sofpironium bromide gel.
Dr Green highlights that an estimated 16 million people in the US experience clinical hyperhidrosis, with a
How to Streamline Study Data to Improve Selection of Therapy for Patients
In this episode of Derms and Conditions, host James Del Rosso, DO, welcomes Ron Vender, MD, Associate Clinical Professor of Dermatology at McMaster University, to discuss practical strategies for psoriasis treatment and the management of chronic hand dermatitis.
They begin with Dr Vender sharing his 90/70/40 rule, a numeric approach to evaluating biologic efficacy in psoriasis. He explains that ac
Dermatology & Social Media: Tips on Engaging with Accuracy and Integrity
In this episode of Derms and Conditions, James Del Rosso, DO, welcomes Dustin Portela, DO, a private practice dermatologist in Boise, ID, and well-known social media presence, to discuss the challenges and responsibilities of dermatologists engaging online while maintaining professional integrity.
Dr Portela shares how he unintentionally became an influencer, initially using social media to market
Hidradenitis Suppurativa: Can You Move the Needle to Achieve Better Outcomes?
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Michael Payette, MD, a dermatologist in private practice at Central Connecticut Dermatology, to discuss practical approaches to managing hidradenitis suppurativa (HS). Dr Payette shares his experience establishing a dedicated HS clinic and provides insights into addressing diagnostic delays, patient education, and emerg
My Pregnancy Test Is Positive and My Eczema Is Bad!” So, What Do We Do Now?
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Mona Shahriari, MD, associate director of clinical trials at Central CT Dermatology and assistant clinical professor at Yale University, to discuss the challenges of treating pregnant and breastfeeding patients, particularly those with atopic dermatitis (AD).
The conversation addresses a crucial yet often unclear topic
Celebrating Episode 100 with the Greatest Hits from Derms and Conditions 2024
In this milestone 100th episode of Derms and Conditions, host James Del Rosso, DO, takes listeners on a year-in-review journey through some of the greatest highlights from 2024. This special solo episode reflects on standout conversations with leading dermatologists and previews exciting plans for 2025.
Dr Del Rosso revisits key insights from some of the most impactful episodes on this 100th Epi
Facing The Challenges of Systemic Therapy Selection for Psoriasis
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, is joined by Brad Glick, DO, dermatologist and residency program director at Larkin Health Center in South Florida, to discuss the complexities of selecting systemic therapies for psoriasis. They share insights on navigating the abundance of treatment options, focusing on patient-centric considerations, with an emphasis on the T
Thinking Beyond the Cytokines: Optimizing Management of Atopic Dermatitis
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes E. James Song, MD, Chief Medical Officer at Frontier Dermatology, to explore the nuances of systemic therapy selection for atopic dermatitis (AD) and offer practical guidance on tailoring treatment plans to optimize outcomes for these patients.
They begin by discussing the importance of considering patient-specific fact
Let's Take It From The Top: Emphasis on Psoriasis
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Tina Bhutani, MD, CEO and clinical dermatologist at Synergy Dermatology in San Francisco, to explore the evolving role of topical corticosteroids in psoriasis care and their interplay with newer nonsteroidal agents. With the wide array of treatments available today, they highlight the enduring importance of topicals in
A Real-World Discussion of Patch Testing in Atopic Patients
In this episode of Derms and Conditions, host James Del Rosso, DO, welcomes David Cotter, MD, a dermatologist in clinical practice and assistant clinical professor at the University of Nevada Las Vegas School of Medicine, to discuss the integral role of patch testing in managing atopic dermatitis (AD) and allergic contact dermatitis (ACD), providing practical insights on incorporating patch testin
A Real-World Conversation: Differentiating and Integrating Therapies for Atopic Dermatitis
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, invites Peter Lio, MD, a clinical professor of dermatology at Northwestern University, to explore the complexities of selecting therapies for atopic dermatitis (AD) with a particular focus on the newly approved IL-13 inhibitor, lebrikizumab. With a growing number of treatment options, Dr Lio and Dr Del Rosso examine how these th
Pediatric Dermatology Research: Doing the Right Things in the Right Way
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Adelaide Hebert, MD, chief of pediatric dermatology at McGovern School of Medicine and Children’s Memorial Hermann Hospital in Houston, to discuss the intricacies and challenges of pediatric clinical research.
They begin by noting that past limitations left clinicians with few FDA-approved treatment options for younger
The Best of Fall Clinical 2024—Live from Las Vegas!
In this special live episode of Derms and Conditions, recorded at the Fall Clinical Dermatology 2024 Meeting, host Dr James Q. Del Rosso welcomes Dr April Armstrong, chief of dermatology at UCLA, to discuss key highlights from the conference. Together, they cover the latest in psoriasis treatments, promising developments for vitiligo, advances in hidradenitis suppurativa, and much more.
The discus
It’s Always Good to Have Options: Expanding the Menu of Treatments for Atopic Dermatitis
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Mona Shahriari, MD, associate director of clinical trials at Central CT Dermatology and assistant clinical professor at Yale University, to discuss the recent FDA approval of lebrikizumab, approved for atopic dermatitis (AD) in patients 12 years of age and up who have failed topical treatments like corticosteroids or ca
Why Are Comorbidities Important in Dermatology? Hear the Answer from the Source!
In this episode of Derms and Conditions, host Dr James Q. Del Rosso welcomes Dr Joel M. Gelfand, Professor of Dermatology and Epidemiology at the University of Pennsylvania, to explore the critical issue of comorbidities in dermatology, with a focus on psoriasis, and address why dermatologists should take an active role in recognizing and addressing these risks.
Dr Gelfand reflects on his early ob
How Does TYK2 March To Its Own Drummer?
In this episode of Derms and Conditions, host James Del Rosso, DO, is joined by Jason Hawkes, MD, a dermatologist and investigator at the Medical Research Center of Oregon, to discuss tyrosine kinase 2 (TYK2) inhibitors, particularly deucravacitinib, for plaque psoriasis. They explain how deucravacitinib, which targets the TYK2 pathway, differs from other JAK inhibitors by avoiding the "off-target
Comprehensive Management of Hidradenitis Suppurativa: Moving the Needle Forward for Our Patients
In this episode of Derms and Conditions, host James Del Rosso sits down with Dr Jessica Kaffenberger, an associate professor in dermatology at Ohio State University in Columbus, Ohio, to discuss the latest in hidradenitis suppurativa (HS) management. From navigating treatment challenges to addressing patient concerns, Dr Kaffenberger shares valuable insights on bridging older therapies with biolog
Raising the Bar in Atopic Dermatitis: Where Are We Now?
In this episode of Derms and Conditions, host James Del Rosso, DO, speaks with Mark Lebwohl, MD, Dean for Clinical Therapeutics at the Icahn School of Medicine at Mount Sinai, about the role of Janus kinase (JAK) inhibitors, particularly upadacitinib, in treating atopic dermatitis. They provide insights into the benefits of JAK inhibitors compared to monoclonal antibodies, patient selection, and t
Topical Nonsteroidal Agents for Psoriasis: Practical Integration with and without Topical Steroids
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, is joined by Omar Noor, MD, co-owner of Rao Dermatology in New York, NY, who shares his expertise on integrating nonsteroidal topical therapies into psoriasis treatment. As systemic therapies continue to advance, Dr Noor emphasizes the enduring importance of topical treatments with a focus on the aryl hydrocarbon receptor agonis
Helping to Make Smart Clinicians Become Even Smarter in Treating Psoriasis
In this episode, our host, James Q. Del Rosso, DO, welcomes Dr Adrian Rodriguez, a dermatologist from Nashville, to discuss the exciting advancements in personalized medicine for psoriasis, particularly focusing on the practical use of a dermal biomedical patch to help clinicians optimize selection of biologics agents for patients with psoriasis.
Dr Rodriguez emphasizes that we're moving into an
Improving Outcomes for Hidradenitis Suppurativa? Picking the Right Partners for the Ultimate Duet
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, and guests Michael Cameron, MD, and James Allred, MD, discuss the intersection of GLP-1 agents and dermatology, exploring how these drugs, initially designed for managing type 2 diabetes, are now offering promising benefits for skin conditions associated with obesity.
They begin by providing an overview of glucagon-like peptide-
Recommended
زن بودن
Medicine with Meaning
Yours Truly Johnny Dollar Collection
Take Back Your Health®
CBS Radio Mystery Theater | Old Time Radio
Solved Murders - True Crime Stories
紐約鳥｜New York Aperture
The Swerve Podcast: Obscure Topics | Conspiracy Theories
The Bread and Banter Podcast
The Church of What's Happening Now: The New Testament
Busted Open
Deadline: White House
